Integration of diagnosis and treatment of pulmonary nodules under multidisciplinary treatment mode_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

ZHANG Xiaowen , ZHU Xiaolei , LIU Hongming , LI Ning , FANG Shaohan ,  GENG Guojun ,  JIANG Jie

Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, Fujian, P. R. China;

Corresponding author：

GENG Guojun, Email: ggj622@126.com; JIANG Jie, Email: jiangjie06@126.com

Keywords：

Pulmonary nodules; lung cancer; multi-disciplinary team; diagnosis; treatment; artificial intelligence

DOI：

10.7507/1007-4848.202112023

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Lung cancer is a disease with high incidence rate and high mortality rate worldwide. Its diagnosis and treatment mode is developing constantly. Among them, multi-disciplinary team (MDT) can provide more accurate diagnosis and more individualized treatment, which can not only benefit more early patients, but also prolong the survival time of late patients. However, MDT diagnosis and treatment mode is only carried out more in provincial and municipal tertiary hospitals and has not been popularized. This article intends to introduce MDT mode and its advantages, hoping that MDT mode can be popularized and applied.

Citation： ZHANG Xiaowen, ZHU Xiaolei, LIU Hongming, LI Ning, FANG Shaohan, GENG Guojun, JIANG Jie. Integration of diagnosis and treatment of pulmonary nodules under multidisciplinary treatment mode. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(7): 806-811. doi: 10.7507/1007-4848.202112023 Copy

1.	滕月, 孙莹莹, 孙夕林, 等. 直径小于1 cm孤立性肺结节的¹⁸F-FDG PET/CT诊断研究进展. 现代生物医学进展, 2020, 20(6): 1193-1196.
2.	Scagliotti G. Improving survival in lung cancer: Commitment of the Lung Ambition Alliance. Am J Manag Care, 2019, 25(12 Spec): Sp387-Sp389.
3.	Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5): 395-409.
4.	钟文昭, 中国胸部肿瘤研究协作组, 中国抗癌协会肺癌专业委员会, 等. 肺癌多学科团队诊疗中国专家共识. 中华肿瘤杂志, 2020, 42(10): 817-828.
5.	Al Zaidi M, Wright GM. Locally advanced non-small cell lung cancer: The place of specialist thoracic surgery in the multidisciplinary team. Transl Lung Cancer Res, 2020, 9(4): 1680-1689.
6.	Adamson AS, Welch HG. Machine learning and the cancer-diagnosis problem—No gold standard. N Engl J Med, 2019, 381(24): 2285-2287.
7.	Nemesure B, Albano D, Bilfinger T. Lung cancer recurrence and mortality outcomes over a 10-year period using a multidisciplinary team approach. Cancer Epidemiol, 2020, 68: 101804.
8.	Gaudioso C, Sykes A, Whalen PE, et al. Impact of a thoracic multidisciplinary conference on lung cancer outcomes. Ann Thorac Surg, 2022, 113(2): 392-398.
9.	吴毓, 蒋旻珏, 贾慧珣, 等. 中国大陆部分医院癌症诊疗模式和临床分期使用情况的调查. 中国癌症杂志, 2015, 25(1): 67-72.
10.	Klarenbeek SE, Schuurbiers-Siebers OCJ, Van Den Heuvel MM, et al. Barriers and facilitators for implementation of a computerized clinical decision support system in lung cancer multidisciplinary team meetings—A qualitative assessment. Biology (Basel), 2020, 10(1).
11.	Petrella F, Radice D, Guarize J, et al. The impact of multidisciplinary team meetings on patient management in oncologic thoracic surgery: A single-center experience. Cancers (Basel), 2021, 13(2).
12.	Kedia SK, Ward KD, Digney SA, et al. 'One-stop shop': Lung cancer patients' and caregivers' perceptions of multidisciplinary care in a community healthcare setting. Transl Lung Cancer Res, 2015, 4(4): 456-64.
13.	Kowalczyk A, Jassem J. Multidisciplinary team care in advanced lung cancer. Transl Lung Cancer Res, 2020, 9(4): 1690-1698.
14.	Grell P, Bořilová S, Bílek O, et al. The role of multidisciplinary team and molecular tumor board in the treatment of a patient with lung cancer. Klin Onkol, 2021, 34(Supplementum 1): 20-28.
15.	Karadurmuş N, Kaya A, Göksel T, et al. Immunotherapy and multidisciplinary approach to treatment in lung cancer. Tuberk Toraks, 2020, 68(1): 66-75.
16.	Beckett P, Woolhouse I. Inequalities in outcomes for non-small cell lung cancer: The role of the MDT. Thorax, 2012, 67(10): 926-927.
17.	Stone E, Rankin N, Kerr S, et al. Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study. Lung Cancer, 2018, 124: 199-204.
18.	Bilfinger TV, Albano D, Perwaiz M, et al. Survival outcomes among lung cancer patients treated using a multidisciplinary team approach. Clin Lung Cancer, 2018, 19(4): 346-351.
19.	Friedman EL, Kruklitis RJ, Patson BJ, et al. Effectiveness of a thoracic multidisciplinary clinic in the treatment of stageⅢ non-small-cell lung cancer. J Multidiscip Healthc, 2016, 9: 267-274.
20.	刘宝东, 支修益. 肺结节、肺癌的一站式管理—从多学科团队到多学科医生. 中国胸心血管外科临床杂志, 2022, 29(3): 288-293.
21.	Roberts TJ, Lennes IT, Hawari S, et al. Integrated, multidisciplinary management of pulmonary nodules can streamline care and improve adherence to recommendations. Oncologist, 2020, 25(5): 431-437.
22.	Croke JM, El-Sayed S. Multidisciplinary management of cancer patients: Chasing a shadow or real value? An overview of the literature. Curr Oncol, 2012, 19(4): e232-e238.
23.	Taylor C, Munro AJ, Glynne-Jones R, et al. Multidisciplinary team working in cancer: What is the evidence? BMJ, 2010, 340: c951.
24.	Bydder S, Nowak A, Marion K, et al. The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non-small cell lung cancer. Intern Med J, 2009, 39(12): 838-841.
25.	Houssami N, Sainsbury R. Breast cancer: Multidisciplinary care and clinical outcomes. Eur J Cancer, 2006, 42(15): 2480-2491.
26.	Patkar V, Acosta D, Davidson T, et al. Cancer multidisciplinary team meetings: Evidence, challenges, and the role of clinical decision support technology. Int J Breast Cancer, 2011, 2011: 831605.
27.	Hardavella G, Frille A, Theochari C, et al. Multidisciplinary care models for patients with lung cancer. Breathe (Sheff), 2020, 16(4): 200076.
28.	Prabhakar CN, Fong KM, Peake MD, et al. The effectiveness of lung cancer MDT and the role of respiratory physicians. Respirology, 2015, 20(6): 884-888.
29.	Lim E, Baldwin D, Beckles M, et al. Guidelines on the radical management of patients with lung cancer. Thorax, 2010, 65 Suppl 3: Ⅲ1-Ⅲ27.
30.	Simmons CP, Koinis F, Fallon MT, et al. Prognosis in advanced lung cancer—A prospective study examining key clinicopathological factors. Lung Cancer, 2015, 88(3): 304-309.
31.	Denton E, Conron M. Improving outcomes in lung cancer: The value of the multidisciplinary health care team. J Multidiscip Healthc, 2016, 9: 137-144.
32.	Popat S, Navani N, Kerr KM, et al. Navigating diagnostic and treatment decisions in non-small cell lung cancer: Expert commentary on the multidisciplinary team approach. Oncologist, 2021, 26(2): e306-e315.
33.	刘鸿鸣, 姜杰, 耿国军. 大数据时代下基于标准化结构化电子病历食管癌数据库的建立与应用. 中国胸心血管外科临床杂志, 2021, 28(5): 499-503.
34.	Ouwens MM, Hermens RR, Termeer RA, et al. Quality of integrated care for patients with nonsmall cell lung cancer: Variations and determinants of care. Cancer, 2007, 110(8): 1782-1790.
35.	范银星, 柴荣, 赵家义, 等. 非小细胞肺癌组织Ki-67与PD-L1表达的相关性及其对患者预后的影响. 中国肿瘤生物治疗杂志, 2019, 26(5): 536-543.
36.	曹孟昆, 姜杰, 朱晓雷, 等. 人工智能肺部结节辅助诊疗系统预测肺结节的良恶性及浸润情况. 中国胸心血管外科临床杂志, 2021, 28(3): 283-287.
37.	邢宇彤, 刘建成, 孙百臣, 等. 区域医疗中心人工智能辅助诊断肺结节的临床应用. 中国胸心血管外科临床杂志, 2021, 28(10): 1178-1182.

1. 滕月, 孙莹莹, 孙夕林, 等. 直径小于1 cm孤立性肺结节的¹⁸F-FDG PET/CT诊断研究进展. 现代生物医学进展, 2020, 20(6): 1193-1196.
2. Scagliotti G. Improving survival in lung cancer: Commitment of the Lung Ambition Alliance. Am J Manag Care, 2019, 25(12 Spec): Sp387-Sp389.
3. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5): 395-409.
4. 钟文昭, 中国胸部肿瘤研究协作组, 中国抗癌协会肺癌专业委员会, 等. 肺癌多学科团队诊疗中国专家共识. 中华肿瘤杂志, 2020, 42(10): 817-828.
5. Al Zaidi M, Wright GM. Locally advanced non-small cell lung cancer: The place of specialist thoracic surgery in the multidisciplinary team. Transl Lung Cancer Res, 2020, 9(4): 1680-1689.
6. Adamson AS, Welch HG. Machine learning and the cancer-diagnosis problem—No gold standard. N Engl J Med, 2019, 381(24): 2285-2287.
7. Nemesure B, Albano D, Bilfinger T. Lung cancer recurrence and mortality outcomes over a 10-year period using a multidisciplinary team approach. Cancer Epidemiol, 2020, 68: 101804.
8. Gaudioso C, Sykes A, Whalen PE, et al. Impact of a thoracic multidisciplinary conference on lung cancer outcomes. Ann Thorac Surg, 2022, 113(2): 392-398.
9. 吴毓, 蒋旻珏, 贾慧珣, 等. 中国大陆部分医院癌症诊疗模式和临床分期使用情况的调查. 中国癌症杂志, 2015, 25(1): 67-72.
10. Klarenbeek SE, Schuurbiers-Siebers OCJ, Van Den Heuvel MM, et al. Barriers and facilitators for implementation of a computerized clinical decision support system in lung cancer multidisciplinary team meetings—A qualitative assessment. Biology (Basel), 2020, 10(1).
11. Petrella F, Radice D, Guarize J, et al. The impact of multidisciplinary team meetings on patient management in oncologic thoracic surgery: A single-center experience. Cancers (Basel), 2021, 13(2).
12. Kedia SK, Ward KD, Digney SA, et al. 'One-stop shop': Lung cancer patients' and caregivers' perceptions of multidisciplinary care in a community healthcare setting. Transl Lung Cancer Res, 2015, 4(4): 456-64.
13. Kowalczyk A, Jassem J. Multidisciplinary team care in advanced lung cancer. Transl Lung Cancer Res, 2020, 9(4): 1690-1698.
14. Grell P, Bořilová S, Bílek O, et al. The role of multidisciplinary team and molecular tumor board in the treatment of a patient with lung cancer. Klin Onkol, 2021, 34(Supplementum 1): 20-28.
15. Karadurmuş N, Kaya A, Göksel T, et al. Immunotherapy and multidisciplinary approach to treatment in lung cancer. Tuberk Toraks, 2020, 68(1): 66-75.
16. Beckett P, Woolhouse I. Inequalities in outcomes for non-small cell lung cancer: The role of the MDT. Thorax, 2012, 67(10): 926-927.
17. Stone E, Rankin N, Kerr S, et al. Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study. Lung Cancer, 2018, 124: 199-204.
18. Bilfinger TV, Albano D, Perwaiz M, et al. Survival outcomes among lung cancer patients treated using a multidisciplinary team approach. Clin Lung Cancer, 2018, 19(4): 346-351.
19. Friedman EL, Kruklitis RJ, Patson BJ, et al. Effectiveness of a thoracic multidisciplinary clinic in the treatment of stageⅢ non-small-cell lung cancer. J Multidiscip Healthc, 2016, 9: 267-274.
20. 刘宝东, 支修益. 肺结节、肺癌的一站式管理—从多学科团队到多学科医生. 中国胸心血管外科临床杂志, 2022, 29(3): 288-293.
21. Roberts TJ, Lennes IT, Hawari S, et al. Integrated, multidisciplinary management of pulmonary nodules can streamline care and improve adherence to recommendations. Oncologist, 2020, 25(5): 431-437.
22. Croke JM, El-Sayed S. Multidisciplinary management of cancer patients: Chasing a shadow or real value? An overview of the literature. Curr Oncol, 2012, 19(4): e232-e238.
23. Taylor C, Munro AJ, Glynne-Jones R, et al. Multidisciplinary team working in cancer: What is the evidence? BMJ, 2010, 340: c951.
24. Bydder S, Nowak A, Marion K, et al. The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non-small cell lung cancer. Intern Med J, 2009, 39(12): 838-841.
25. Houssami N, Sainsbury R. Breast cancer: Multidisciplinary care and clinical outcomes. Eur J Cancer, 2006, 42(15): 2480-2491.
26. Patkar V, Acosta D, Davidson T, et al. Cancer multidisciplinary team meetings: Evidence, challenges, and the role of clinical decision support technology. Int J Breast Cancer, 2011, 2011: 831605.
27. Hardavella G, Frille A, Theochari C, et al. Multidisciplinary care models for patients with lung cancer. Breathe (Sheff), 2020, 16(4): 200076.
28. Prabhakar CN, Fong KM, Peake MD, et al. The effectiveness of lung cancer MDT and the role of respiratory physicians. Respirology, 2015, 20(6): 884-888.
29. Lim E, Baldwin D, Beckles M, et al. Guidelines on the radical management of patients with lung cancer. Thorax, 2010, 65 Suppl 3: Ⅲ1-Ⅲ27.
30. Simmons CP, Koinis F, Fallon MT, et al. Prognosis in advanced lung cancer—A prospective study examining key clinicopathological factors. Lung Cancer, 2015, 88(3): 304-309.
31. Denton E, Conron M. Improving outcomes in lung cancer: The value of the multidisciplinary health care team. J Multidiscip Healthc, 2016, 9: 137-144.
32. Popat S, Navani N, Kerr KM, et al. Navigating diagnostic and treatment decisions in non-small cell lung cancer: Expert commentary on the multidisciplinary team approach. Oncologist, 2021, 26(2): e306-e315.
33. 刘鸿鸣, 姜杰, 耿国军. 大数据时代下基于标准化结构化电子病历食管癌数据库的建立与应用. 中国胸心血管外科临床杂志, 2021, 28(5): 499-503.
34. Ouwens MM, Hermens RR, Termeer RA, et al. Quality of integrated care for patients with nonsmall cell lung cancer: Variations and determinants of care. Cancer, 2007, 110(8): 1782-1790.
35. 范银星, 柴荣, 赵家义, 等. 非小细胞肺癌组织Ki-67与PD-L1表达的相关性及其对患者预后的影响. 中国肿瘤生物治疗杂志, 2019, 26(5): 536-543.
36. 曹孟昆, 姜杰, 朱晓雷, 等. 人工智能肺部结节辅助诊疗系统预测肺结节的良恶性及浸润情况. 中国胸心血管外科临床杂志, 2021, 28(3): 283-287.
37. 邢宇彤, 刘建成, 孙百臣, 等. 区域医疗中心人工智能辅助诊断肺结节的临床应用. 中国胸心血管外科临床杂志, 2021, 28(10): 1178-1182.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Integration of diagnosis and treatment of pulmonary nodules under multidisciplinary treatment mode

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content